Immunosuppressive properties of human PD-1+ PDL-1+ dendritic cell from Lymph Nodes Aspirates of NSCLC patients.

I. Kwiecien (Warsaw, Poland), E. Rutkowska (Warsaw, Poland), R. Sokolowski (Warsaw, Poland), J. Bednarek (Warsaw, Poland), A. Raniszewska (Warsaw, Poland), K. Jahnz-Rózyk (Warsaw, Poland), P. Rzeepecki (Warsaw, Poland), J. Domagala-Kulawik (Warsaw, Poland)

Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Session: Molecular alterations and immunology in lung cancer
Session type: E-poster session
Number: 1656
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Kwiecien (Warsaw, Poland), E. Rutkowska (Warsaw, Poland), R. Sokolowski (Warsaw, Poland), J. Bednarek (Warsaw, Poland), A. Raniszewska (Warsaw, Poland), K. Jahnz-Rózyk (Warsaw, Poland), P. Rzeepecki (Warsaw, Poland), J. Domagala-Kulawik (Warsaw, Poland). Immunosuppressive properties of human PD-1+ PDL-1+ dendritic cell from Lymph Nodes Aspirates of NSCLC patients.. 1656

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Human dendritic cells with PD-1+ CD80+ expression from lymph nodes aspirates of sarcoidosis patients.
Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Year: 2021


Immunomodulating properties of PD-L1 positive cancer stem cells in metastatic lymph nodes
Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer
Year: 2019



Immunomodulating properties of FasL+ lung cancer cells identified in lymph nodes aspirates of NSCLC patients
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodes
Source: ERJ Open Res, 3 (2) 00110-2016; 10.1183/23120541.00110-2016
Year: 2017



PD-L1 expression on lung cancer stem cells in metastatic lymph nodes.
Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management
Year: 2018



High fold-changes in peripheral blood PD-1+ CD8+ T cells expressing Granzyme B predicts the response to immunotherapy in NSCLC
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010


Expression of CD1a cells and VCAM in large airways and thoracic lymph nodes of fatal asthma
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013

BALF changes of CD4+, CD8+ cells in lung cancer patients with different chemotherapeutic regimens
Source: Annual Congress 2008 - Treatment of thoracic tumours
Year: 2008

T cell maturation profile in metastatic vs. non-metastatic lymph nodes in NSCLC patients
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


Recombination of B7-H4 and CD68 predicted lymph node metastasis in human lung carcinoma
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013


Immunoglobulin-like transcripts 3 (ILT3) expression in human lung adenocarcinoma as a novel regulator of intratumoral lymphoid follicle formation
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

Tumour-infiltrating CD8+ cells expressing IL-10, but not CD8+, CD4+ and CD68+ cells, are associated with a better prognosis in patients with NSCLC
Source: Annual Congress 2008 - Airway cell biology
Year: 2008


Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses tumor-specific T cell immunity
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012

Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells
Source: Eur Respir J 2009; 34: 162-175
Year: 2009



Influence of IL-17 on transcriptional profiles of lung and peribronchial lymph nodes dendritic cells in steady and antigen exposed conditions
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019

Diminished levels of IL-7 receptor-positive CD4+ T cells in asthmatic patients are up-regulated by glucocorticoid therapy. No effects on IL-7R-negative regulatory CD4+ T cells
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010


Increased T-regulatory cells in lungs and draining lymph nodes in a murine model of COPD
Source: Eur Respir J 2010; 35: 688-689
Year: 2010


Lung CD8+ T cells of COPD patients have low cytotoxic potential and high expression of the inhibitory receptor NKG2A
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009


Regulatory vs. cytotoxic cells in lymph nodes of lung cancer patients resected by TEMLA
Source: International Congress 2016 – Lung cancer immunology: latest research
Year: 2016